BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22511020)

  • 21. [Criteria for the resectability of malignant extrahepatic bile duct tumours].
    Kissenkoetter S; Witzigmann H
    Zentralbl Chir; 2012 Feb; 137(1):32-7. PubMed ID: 22344835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
    Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
    In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX; Zhang ZW; Xu ZY
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Machino R; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012; 59(114):347-50. PubMed ID: 22353497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hilar cholangiocarcinoma: right versus left hepatectomy].
    Otto G; Heise M; Hoppe-Lotichius M; Pitton M; Hansen T
    Zentralbl Chir; 2012 Dec; 137(6):535-40. PubMed ID: 23264194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III.
    Grandadam S; Compagnon P; Arnaud A; Olivié D; Malledant Y; Meunier B; Launois B; Boudjema K
    Ann Surg Oncol; 2010 Dec; 17(12):3155-61. PubMed ID: 20593243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
    Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
    Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biliary cholangiocarcinoma].
    Castaing D
    Ann Chir; 1998; 52(2):177-81. PubMed ID: 9752437
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative surgery for hilar cholangiocarcinoma.
    Li HM; Dou KF; Sun K; Gao ZQ; Li KZ; Fu YC
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):110-3. PubMed ID: 14607660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
    Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
    Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for cholangiocarcinoma.
    Franco D; Usatoff V
    Hepatogastroenterology; 2001; 48(37):53-5. PubMed ID: 11268998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current therapy of hilar cholangiocarcinoma.
    Lau SH; Lau WY
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):12-7. PubMed ID: 22251465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new technique for assessing the resectability of hilar cholangiocarcinoma: lifting of the umbilical portion of the portal vein.
    Shirai Y; Yamai K; Ohtani T; Tsukada K; Hatakeyama K
    J Am Coll Surg; 1997 Jan; 184(1):80-3. PubMed ID: 8989306
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical treatment for intrahepatic cholangiocarcinoma].
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():469-75. PubMed ID: 16457307
    [No Abstract]   [Full Text] [Related]  

  • 40. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation.
    Petrowsky H; Hong JC
    Transplant Proc; 2009 Dec; 41(10):4023-35. PubMed ID: 20005336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.